These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 10064010

  • 1. Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model.
    Burke SE, Lubbers NL, Nelson RA, Wegner CD, Cox BF.
    Thromb Haemost; 1999 Feb; 81(2):301-5. PubMed ID: 10064010
    [Abstract] [Full Text] [Related]

  • 2. Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model.
    Burke SE, Lubbers NL, Nelson RA, Henkin J.
    Thromb Haemost; 1997 May; 77(5):1025-30. PubMed ID: 9184422
    [Abstract] [Full Text] [Related]

  • 3. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial.
    Ouriel K, Kandarpa K, Schuerr DM, Hultquist M, Hodkinson G, Wallin B.
    J Vasc Interv Radiol; 1999 Sep; 10(8):1083-91. PubMed ID: 10496712
    [Abstract] [Full Text] [Related]

  • 4. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR, Wu Z, Pauwels P, Lijnen HR, Collen D.
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [Abstract] [Full Text] [Related]

  • 5. Recombinant pro-urokinase requires heparin for optimal clot lysis and restoration of blood flow in a canine femoral artery thrombosis model.
    Burke SE, Lubbers NL, Nelson RA, Henkin J.
    Thromb Haemost; 1993 Apr 01; 69(4):375-80. PubMed ID: 8497850
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of Lys- and mini-plasminogen on clot lysis induced by recombinant urokinase and recombinant pro-urokinase in a canine thrombosis model.
    Burke SE, Davidson DJ, Lubbers NL, Reininger IM, Henkin J.
    Thromb Res; 1996 Sep 15; 83(6):421-31. PubMed ID: 8885137
    [Abstract] [Full Text] [Related]

  • 7. Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase.
    Credo RB, Burke SE.
    J Vasc Interv Radiol; 1995 Sep 15; 6(6 Pt 2 Suppl):8S-18S. PubMed ID: 8770836
    [Abstract] [Full Text] [Related]

  • 8. Comparison of intravenous bolus injection or continuous infusion of recombinant single chain urokinase-type plasminogen activator (saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosis.
    Rapold HJ, Wu ZM, Stassen T, Van de Werf F, Collen D.
    Blood; 1990 Oct 15; 76(8):1558-63. PubMed ID: 2119830
    [Abstract] [Full Text] [Related]

  • 9. Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusion.
    Nakada MT, Montgomery MO, Nedelman MA, Guerrero JL, Cohen SA, Barnathan ES, Jordan RE.
    J Vasc Interv Radiol; 2004 Feb 15; 15(2 Pt 1):169-76. PubMed ID: 14963184
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of the thrombolytic efficacy of prourokinase by lys-plasminogen in a dog model of arterial thrombosis.
    Badylak SF, Voytik SL, Henkin J, Burke SE, Sasahara AA, Simmons A.
    Thromb Res; 1991 May 01; 62(3):115-26. PubMed ID: 1716378
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel chimaeric derivative of saruplase, rscu-PA-40 kDA/Hir, binds to thrombin and exerts thrombus-specific fibrinolysis in arterial and venous thrombosis in dogs.
    Schneider J, Hauser R, Hennies HH, Korioth J, Steffens G, Wnendt S.
    Thromb Haemost; 1997 Mar 01; 77(3):535-9. PubMed ID: 9066007
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regional low dosage thrombolytic therapy for peripheral arterial occlusions.
    Hallett JW, Yrizarry JM, Greenwood LH.
    Surg Gynecol Obstet; 1983 Feb 01; 156(2):148-54. PubMed ID: 6218633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Local thrombolysis in peripheral arterial occlusion].
    Hess H.
    Herz; 1989 Feb 01; 14(1):12-21. PubMed ID: 2522076
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.